Chronic venous insufficiency and the therapeutic effects of Daflon 500 mg

Angiology

Volumn 56, Issue SUPPL. 1, 2005, Pages

  Bergan, John J ^a,b  

^a University of California ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAFLON;

CAVA VEIN; CHRONIC INFLAMMATION; CHRONIC VEIN INSUFFICIENCY; CLINICAL TRIAL; COMPRESSION THERAPY; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; ENDOTHELIUM; FEMORAL VEIN; HEART RIGHT ATRIUM; HEMODYNAMICS; HUMAN; HYPERTENSION; ILIAC VEIN; LEUKOCYTE ACTIVATION; MUSCLE CONTRACTION; NEUTROPHIL CHEMOTAXIS; SHEAR STRESS; SUBCUTANEOUS TISSUE; TABLET; TREATMENT OUTCOME; ULCER HEALING; VEIN PERFORATION; VENOUS PRESSURE; VENULE; ARTICLE; CLINICAL TRIAL (TOPIC); LIPODERMATOSCLEROSIS; NONHUMAN; VASCULAR REMODELING;

EID: 25444496749     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Nicolaides AN: Investigation of chronic venous insufficiency: A consensus statement (France, March 5-9, 1997). Circulation 102:E126-163, 2000.
2. Takase S, Lerond L, Bergan JJ, et al: The inflammatory reaction during venous hypertension in the rat. Microcirculation 7:41-52, 2000.
3. Buján J, Jurado F, Gimeno MJ, et al: Changes in metalloproteinase (MMP-1, MMP-2) expression in the proximal region of the varicose saphenous vein in young subjects. Phlebology 15:64-70, 2000.
4. Ono T, Bergan JJ, Schmid-Schönbein GW, et al: Monocyte infiltration into venous valves. J Vasc Surg 27:158-166, 1998.
5. Takase S, Schmid-Schönbein G, Bergan JJ: Leukocyte activation in patients with venous insufficiency. J Vasc Surg 30:148-156, 1999.
6. Bergan JJ: Surgical management of primary and recurrent varicose veins. In: Handbook of Venous Disorders, ed. by Gloviczki P, Yao JST. London: Chapman and Hall, 1996.
7. Arnoldi CC: In: Controversies in the Management of Venous Disorders, ed. by Eklöf B, Gjöres JE, Thulesius O, et al. London: Butterworths, 1989, p 13.
8. Bjordal RI: Circulation patterns in incompetent perforating veins in the calf and in the saphenous system in primary varicose veins. Acta Chir Scand 138:251-261, 1972.
9. Hahn TL, Unthank JL, Lalka SG: Increased hindlimb leukocyte concentration in a chronic rodent model of venous hypertension. J Surg Res 81:38-41, 1999.
10. Nicolaides AN, Sumner DS: Ambulatory venous pressure measurements. In: Investigations of Patients with Deep Venous Thrombosis and Chronic Venous Insufficiency, ed. by Nicolaides AN, Sumner DS. London: Med-Orion, 1991, pp 29-31.
11. Pappas PJ, Fallek SR, Garcia A, et al: Role of leukocyte activation in patients with venous stasis ulcers. J Surg Res 59:553-558, 1995.
12. Pappas PJ, You R, Rameshwar P, et al: Dermal tissue fibrosis in patients with chronic venous insufficiency is associated with increased transforming growth factor-1 gene expression and protein production. J Vasc Surg 30:1129-1145, 1999.
13. Gradman WS, Segalowitz J, Grundfest W: Venoscopy in varicose vein surgery: Initial Experience. Phlebology 8:145-150, 1993.
14. Van Cleef JF, Desvaux P, Hugentobler JP, et al: Endoscopie veineuse. J Mal Vasc 16:184-187, 1991.
15. Blanchemaison P: Significance of venous endoscopy in the exploration and the treatment of venous insufficiency of the legs [in French], J Mal Vasc 17(suppl B):109-112, 1992.
16. Schmid-Schonbein GW, Takase S, Bergan JJ: New advances in the understanding of the pathophysiology of chronic venous insufficiency. Angiology 52(suppl 1):S27-S34, 2001.
17. Simon SI, Goldsmith HL: Leukocyte adhesion dynamics in shear flow. Ann Biomed Eng 30:315-332, 2002.
18. Nagel T, Resnick N, Atkinson WJ, et al: Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells. J Clin Invest 94:885-891, 1994.
19. Takase S, Pascarella L, Bergan JJ, et al: Hypertension induced valve remodeling. J Vasc Surg 39:1329-1335, 2004.
20. Ortega F, Mompeo B, Sarmiento L, et al: Comparison of saphenous veins removed for primary venous insufficiency with cadaver saphenous veins. Vasc Surg 31:663-670, 1997.
21. Friesnecker B, Tsai AG, Allegra C, et al: Oral administration of purified micronised flavonoid fraction suppresses leukocyte adhesion in ischemia-perfusion injury. Int J Microcirc 14:50-55, 1994.
22. Korthuis RJ, Gute DC: Post ischemic leukocyte/endothelial cell interactions and microvascular barrier disruption in skeletal muscle: Cellular mechanisms and the effect of Daflon 500 mg. Int J Mirocirc 17(suppl 1):11-17, 1997.
23. Takase S, Lerond L, Bergan JJ, et al: Enhancement of reperfusion injury by elevation of microvascular pressures. Am J Physiol Heart Circ 282:H1387-H1394, 2002.
24. Takase S, Delano FA, Lerond L, et al: Inflammation in chronic venous insufficiency: Is the problem insurmountable? J Vasc Res 36(suppl 1):3-10, 1999.
25. Guilhou JJ, Dereure O, Marzin L, et al: Efficacy of Daflon 500 mg in venous leg ulcer healing: A double-blind, randomized, controlled versus placebo trial in 107 patients. Angiology 48:77-85, 1997.